Biological hazards in clinical laboratories [Riesgos biológicos en laboratorios clínicos]

Authors

  • Diego Armando Flores-Pilco Autonomous Regional University of the Andes. UNIANDES, Ambato - Ecuador

DOI:

https://doi.org/10.62574/rmpi.v2i4.90

Keywords:

working conditions, occupational safety, safety measures

Abstract

The objective of this research is to analyze the biological risks in clinical laboratories in the city of Ambato - Ecuador. A descriptive type of research was developed. The biological risk found in laboratories that handle dangerous samples such as viruses and bacteria, must have all the protective measures to avoid the contagion of laboratorians, it is necessary to identify the best protocol for the care of the professional starting from biosafety standards and especially the transport, handling and storage of the sample, thus avoiding a large percentage of the level of contagion by exposure. These are the microorganisms that were found in the areas of the different private clinical laboratories in the city of Ambato, caused by the handling of biological agents, and these can cause serious diseases such as HIV, Hepatitis A, Hepatitis B, Tuberculosis, different Pneumonias, Influenza and Covid-19.

Downloads

Download data is not yet available.

References

Bentrón, Flavio. (2020). Riesgos biologicos en laboratorios clinicos de la ciudad de Portoviejo mediante el metodo Biogaval [Biological risks in clinical laboratories in the city of Portoviejo using the Biogaval method]. San Gregorio, 1(40), 112- 120.

Inal, Tamer, Goruroglu Ozturk, Özlem, Kibar, F., Cetiner, S., Matyar, S., Daglioglu, G., & Yaman, Akgun. (2018). Lean six sigma methodologies improve clinical laboratory efficiency and reduce turnaround times. Journal of clinical laboratory analysis, 32(1), e22180. https://doi.org/10.1002/jcla.22180

Lippi, Giuseppe, Adeli, K., Ferrari, M., Horvath, A. R., Koch, D., Sethi, S., & Wang, C. B. (2020). Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations. Clinical chemistry and laboratory medicine, 58(7), 1053–1062. https://doi.org/10.1515/cclm-2020-0633

Loh, T. P., Horvath, A. R., Wang, C. B., Koch, D., Adeli, K., Mancini, N., Ferrari, M., Hawkins, R., Sethi, S., Lippi, G., & International Federation of Clinical Chemistry and Laboratory Medicine Taskforce on COVID-19 (2020). Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: an IFCC global survey. Clinical chemistry and laboratory medicine, 58(9), 1441–1449. https://doi.org/10.1515/cclm-2020-0710

Patel, Robin. (2016). New Developments in Clinical Bacteriology Laboratories. Mayo Clinic proceedings, 91(10), 1448–1459. https://doi.org/10.1016/j.mayocp.2016.06.020

Peng, Huasong, Bilal, Mohamed, & Iqbal, Hafiz. (2018). Improved Biosafety and Biosecurity Measures and/or Strategies to Tackle Laboratory-Acquired Infections and Related Risks. International journal of environmental research and public health, 15(12), 2697. https://doi.org/10.3390/ijerph15122697

Pérez-Díaz, Yilian, Pedroso-Ramos, Lucía, & Pérez-Santoya, Lázaro. (2020). Evaluación del riesgo biológico en laboratorio clínico aplicando el método BIOGAVAL. Medimay, 27(2), 104-116.

Porru, Stefano, Chiappin, Marco, & Sfriso, Nicolo. (2019). Rischio biologico nei laboratori di ricerca [Biohazards in research laboratories]. Giornale italiano di medicina del lavoro ed ergonomia, 41(4), 359–364.

Wang, Kaijin, Zhu, Xuetong, & Xu, Jiancheng. (2020). Laboratory Biosafety Considerations of SARS-CoV-2 at Biosafety Level 2. Health security, 18(3), 232–236. https://doi.org/10.1089/hs.2020.0021

Wurtz, N., Papa, A., Hukic, M., Di Caro, A., Leparc-Goffart, I., Leroy, E., Landini, M. P., Sekeyova, Z., Dumler, J. S., Bădescu, D., Busquets, N., Calistri, A., Parolin, C., Palù, G., Christova, I., Maurin, M., La Scola, B., & Raoult, D. (2016). Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 35(8), 1247–1258. https://doi.org/10.1007/s10096-016-2657-1

Published

2022-10-01

How to Cite

Flores-Pilco, D. A. . (2022). Biological hazards in clinical laboratories [Riesgos biológicos en laboratorios clínicos]. Multidisciplinary Journal Investigative Perspectives/Revista Multidisciplinaria Perspectivas Investigativas, 2(4), 10–14. https://doi.org/10.62574/rmpi.v2i4.90